DISCOVERY THERAPEUTICS CARIBE

Lobbying client · Ohio · filed 2025 to 2025

Late-stage Ohio biotech company

$0 Reported spend

2 Filings counted

1 Outside firm hired

0 Bills named

Spend is reported income plus in-house expenses across 2 filings. Everything on this page comes from one LDA client record (60185), filed by the registrant listed below.

Who filed for this client 1

LNE GROUP $0 Outside firm · 2 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Reported by year 1 year

2025 $0 2 filings

Issues lobbied 1

Health Issues 1

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 1
SENATE 1

Recent filings 2 total

Q2 terminationNo activity

LNE GROUP

2nd Quarter 2025 (Apr 1 - June 30) · posted Jul 21, 2025

View → Q1 report

LNE GROUP

1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · posted Apr 21, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.